Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higenamine vs adenosine for nuclear myocardial perfusion imaging in coronary artery disease
CTR20202612Phase 3Completed
- Sponsor
- Zhuhai Rundu Pharmaceutical
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of higenamine in coronary arteriosclerosis, sponsored by Zhuhai Rundu Pharmaceutical. Started Dec 2020; status: completed.
02
Drugs
higenamine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on CTR20202612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202612.